close
MENU
Hot Topic NBR Focus: GMO
Hot Topic NBR Focus: GMO
4 mins to read

Analyst downgrades Xero to sell on US concerns — Drury responds

Wed, 02 Jul 2014

When NBR last caught up with Woodward Partners Equities' Nick Lewis, early April, he raised the possibility that Xero [NZX: XRO] shares could fall to the mid-teens if things go against it in the key US market.

His July 1 research note isn't that harsh, in the final event — but it isn't that far

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

NZ$399.00 / yearly

Offer ends July 31st

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Analyst downgrades Xero to sell on US concerns — Drury responds
39285
true